Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Current Assets (2020 - 2025)

iSpecimen has reported Current Assets over the past 6 years, most recently at $7.0 million for Q4 2025.

  • Quarterly results put Current Assets at $7.0 million for Q4 2025, up 93.83% from a year ago — trailing twelve months through Dec 2025 was $7.0 million (up 93.83% YoY), and the annual figure for FY2025 was $7.0 million, up 93.83%.
  • Current Assets for Q4 2025 was $7.0 million at iSpecimen, up from $3.6 million in the prior quarter.
  • Over the last five years, Current Assets for ISPC hit a ceiling of $32.9 million in Q4 2021 and a floor of $1.2 million in Q2 2025.
  • Median Current Assets over the past 5 years was $9.1 million (2023), compared with a mean of $12.8 million.
  • Biggest five-year swings in Current Assets: soared 848.87% in 2021 and later crashed 77.72% in 2025.
  • iSpecimen's Current Assets stood at $32.9 million in 2021, then plummeted by 40.28% to $19.7 million in 2022, then crashed by 58.13% to $8.2 million in 2023, then tumbled by 56.45% to $3.6 million in 2024, then skyrocketed by 93.83% to $7.0 million in 2025.
  • The last three reported values for Current Assets were $7.0 million (Q4 2025), $3.6 million (Q3 2025), and $1.2 million (Q2 2025) per Business Quant data.